Cleared Traditional

Micro-current Facial Beauty Device (AM-810B, AM-810W, AM-812B, AM-812W) (K243430) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
44d
Days
Class 2
Risk

K243430 is an FDA 510(k) clearance for the Micro-current Facial Beauty Device (AM-810B, AM-810W, AM-812B, AM-812W). Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Shenzhen Aozemei Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 19, 2024 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Shenzhen Aozemei Technology Co., Ltd. devices

Submission Details

510(k) Number K243430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 05, 2024
Decision Date December 19, 2024
Days to Decision 44 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 148d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Feiying Drug & Medical Consulting Technical Service Group
Riley Chen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K243430.
Myolight Microcurrent Handpiece
K243063 · Raja Trading Company, Inc. · Feb 2025
JMOON NouvelleSkin Facial Toning Device (M30U PR, M30U MW, M30U SG, M30U SK, M30U MP)
K243393 · Shenzhen Ulike Smart Electronics Co., Ltd. · Feb 2025
Medi Lift Mask
K244048 · Ya-Man, Ltd. · Jan 2025
BTL-785BNF-E
K242532 · BTL Industries, Inc. · Dec 2024
NuFACE® FIX+
K240564 · Carol Cole Company Dba Nuface · Jun 2024
BEAR 2 Body
K232242 · Foreo, Inc. · May 2024